ARCHIVES

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC

July 2, 1999

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009

NCI Workshop Summary “Incomplete,” Kopans Writes In Letter

April 16, 1993

Foundations Invites Antitobacco Proposals

October 15, 1993

Congressman Carter To Address ACCC Annual Conference

December 3, 1976